Cochlear Temettü

Temettü kriter kontrolleri 2/6

Cochlear kazançlarla iyi bir şekilde karşılanan, 1.48% cari getiriye sahip, temettü ödeyen bir şirkettir.

Anahtar bilgiler

1.5%

Temettü verimi

75%

Ödeme oranı

Sektör ortalama getirisi	1.6%
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	AU$4.200
Hisse başına kazanç	AU$5.45
Temettü verim tahmini	2.0%

Son temettü güncellemeleri

Recent updates

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: COH şirketinin temettü ödemeleri son 10 yıldır dalgalı seyretti.

Büyüyen Temettü: COH şirketinin temettü ödemeleri son 10 yıldır artış göstermektedir.

Piyasaya Karşı Temettü Getirisi

Cochlear Piyasaya Karşı Temettü Getirisi

COH temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (COH)	1.5%
Pazarın Alt %25'i (AU)	2.6%
Pazarın En İyi %25'i (AU)	6.0%
Sektör Ortalaması (Medical Equipment)	1.6%
Analist tahmini (COH) (3 yıla kadar)	2.0%

Önemli Temettü: COH şirketinin temettüsü ( 1.44% ), Australian pazarındaki temettü ödeyenlerin en alttaki %25'ine ( 2.62% ) kıyasla dikkate değer değil.

Yüksek Temettü: COH 'in temettüsü ( 1.44% ), Australian piyasasındaki temettü ödeyenlerin en üst %25'ine ( 5.94% ) kıyasla düşüktür.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Mevcut ödeme oranı ( 75.3% ) ile COH 'un ödemeleri kazançlarla karşılanmaktadır.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Yüksek nakit ödeme oranı ( 91.9% ) nedeniyle, COH 'un temettü ödemeleri nakit akışları tarafından yeterince karşılanmıyor.

Cochlear Temettü

Temettü kriter kontrolleri 2/6

Anahtar bilgiler

Son temettü güncellemeleri

Upcoming dividend of AU$2.10 per share

Cochlear Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, 2024, Payable on October 10, 2024

Upcoming dividend of AU$2.00 per share

Upcoming dividend of AU$1.75 per share at 1.2% yield

Upcoming dividend of AU$1.55 per share at 1.3% yield

Upcoming dividend of AU$1.45 per share

Recent updates

Now 20% overvalued

Stu Sayers to Appoint as President, Asia Pacific & Latin America of Cochlear Limited, Effective from 1 January 2025

Upcoming dividend of AU$2.10 per share

Cochlear Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, 2024, Payable on October 10, 2024

Full year 2024 earnings released: EPS: AU$5.45 (vs AU$4.57 in FY 2023)

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old

Upcoming dividend of AU$2.00 per share

First half 2024 earnings released: EPS: AU$2.92 (vs AU$2.15 in 1H 2023)

Upcoming dividend of AU$1.75 per share at 1.2% yield

Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T

Cochlear Limited to Report Fiscal Year 2024 Results on Aug 15, 2024

Full year 2023 earnings released: EPS: AU$4.57 (vs AU$4.40 in FY 2022)

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Upcoming dividend of AU$1.55 per share at 1.3% yield

Cochlear Limited Provides Earnings Outlook for the Year 2023

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Cochlear Limited, Annual General Meeting, Oct 17, 2023

FDA Approves Cochlear Limited's Nucleus 8 Sound Processor, Smaller, Smarter, Better Connected Cochlear Implant Technology

Key Executive recently bought AU$97k worth of stock

Upcoming dividend of AU$1.45 per share

Full year 2022 earnings released: EPS: AU$4.40 (vs AU$4.93 in FY 2021)

Cochlear Announces Final Dividend Payable on 17 October 2022

Cochlear Limited Appoints Karen Penrose to Board, Effective on 1 July 2022

Cochlear Limited, Annual General Meeting, Oct 18, 2022

Cochlear Limited to Report First Half, 2023 Results on Feb 15, 2023

Upcoming dividend of AU$1.55 per share

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Cochlear Limited Announces Interim Dividend Expected to Be Payable on 21 April 2022

FDA Approves Cochlear Nucleus Implants for Unilateral Hearing Loss/Single-Sided Deafness

Independent Non-Executive Director recently bought AU$56k worth of stock

Cochlear Limited Advises of US Patent Infringement Complaint

Upcoming dividend of AU$1.40 per share

Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing Preservation in Combination with Cochlear Implantation

Independent Non-Executive Director recently bought AU$94k worth of stock

Independent Chairman Roderic Holliday-Smith has left the company

Full year 2021 earnings released: EPS AU$4.97 (vs AU$4.00 loss in FY 2020)

Cochlear Limited Provides Earnings Guidance for the Fiscal Year 2022

Non-Executive Independent Director Abbas Hussain has left the company

New Cochlear CoPilot app to help adults improve hearing outcomes through skills training

Upcoming Dividend of AU$1.15 Per Share

Cochlear Receives FDA Clearance of Baha 6 Max, Industry's Smallest 55 dB Sound Processor Now with Direct Android Streaming

Independent Non-Executive Director recently bought AU$164k worth of stock

Cochlear Limited Receives US Food and Drug Administration Approval for Baha 6 Max Sound Processor

First half 2021 earnings released: EPS AU$3.59 (vs AU$2.73 in 1H 2020)

Revenue beats expectations

Cochlear Limited Appoints Stu Sayers as Chief Financial Officer

New 90-day low: AU$189

New 90-day low: AU$194

Cochlear Limited Appoints Stu Sayers as Acting CFO

New 90-day high: AU$233

Cochlear Limited Appoints Stephen Mayne as Director

Cochlear Limited to Report Fiscal Year 2021 Results on Aug 20, 2021

Cochlear Limited to Report Fiscal Year 2020 Results on Aug 18, 2020

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin